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The ubiquitously expressed kinase GRK2 protects against cellular overstimulation by desensitizing G protein-coupled receptors and regulating intracellular signaling. Recently, we described that hypoxiaischemia (HI)-induced brain damage was accelerated and increased in GRK2 +/À neonatal mice. Using
Cre-Lox technology we now investigated the role of decreased GRK2 in only microglia/macrophages or forebrain neurons in development of HI brain injury. Low GRK2 in microglia/macrophages (LysM-GRK2 f/+ mice) was sufficient to accelerate onset of HI damage, without affecting the severity of brain injury at 24 h post-HI as compared to LysM-GRK2 +/+ littermates. Consistently, the ipsilateral hemisphere of GRK2 +/À mice contained microglia with a more rounded phenotype compared to WT mice at 3 h post-HI. Inhibition of microglial/macrophage activity by minocycline treatment prevented the early onset of HI injury in GRK2 +/À mice. In vitro, primary GRK2 +/À microglia stimulated with LPS produced more TNF-a than WT microglia via a p38-dependent pathway. In vivo, HI-induced cerebral p38 activation and TNF-a production were increased in GRK2 +/À mice or in LysM-GRK2 f/+ mice. Our findings indicate that low GRK2 in microglia/macrophages accelerates brain damage via a GRK2/p38/TNF-a-dependent pathway. Reduced GRK2 only in forebrain neurons (CamKIIa-GRK2 f/+ mice) significantly increased severity of HI brain damage without affecting the onset of brain damage.
In conclusion, our data indicate that low GRK2 in microglia/macrophages facilitates activation of these cells which may contribute to the earlier onset of cerebral HI injury associated with increased p38 phosphorylation and TNF-a production. The level of GRK2 in neurons is crucial for determining the ultimate severity of HI damage in the newborn brain.
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Introduction
Perinatal hypoxia-ischemia (HI) often leads to serious and permanent brain injury in the human neonate. The underlying mechanisms leading to cell death in the brain after HI are numerous and complex and only partially understood (Ferriero, 2004) .
We have shown previously that the level of G protein-coupled receptor kinase 2 (GRK2) in whole brain homogenates is decreased after neonatal HI (Lombardi et al., 2004; Nijboer et al., 2008) . Cerebral GRK2 expression is also reduced in animal models of Alzheimer and Parkinson disease (Burgos-Ramos et al., 2008; Suo et al., 2004; Ahmed et al., 2008) . Moreover, GRK2 +/À mice that express 50% of the protein develop both earlier and more pronounced brain injury after exposure to neonatal HI (Nijboer et al., 2008) . Homozygous GRK2 À/À mice die in utero (Jaber et al., 1996) .
GRKs are key kinases involved in regulation of signaling via G protein-coupled receptors (GPCR) such as chemokine receptors and metabotropic glutamate receptors, via a process called homologous desensitization. More recently, it has been revealed that GRK2 also regulates cellular signaling by direct interaction with several downstream molecules including p38 MAP kinase (Reiter and Lefkowitz, 2006; Ribas et al., 2007) . In vitro studies have demonstrated that GRK2 binds and phosphorylates p38 MAP kinase, thereby preventing activation of p38 (Peregrin et al., 2006) . GRK2 can thus function as an endogenous p38 inhibitor in vitro. However, the in vivo relevance of changes in GRK2 for p38-dependent processes is unknown. Numerous factors that contribute to brain injury, like reactive oxygen species and cytokines, upregulate the activity of p38 (Cuenda and Rousseau, 2007) . In addition, p38 is a major kinase involved in microglial activation and cytokine
